RECURSION PHARMACEUTICALS IN's ticker is and the CUSIP is 75629V954. A total of 3 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,123 | +1870.2% | 146,900 | +1807.8% | 0.00% | – |
| Q2 2023 | $57 | +418.2% | 7,700 | +352.9% | 0.00% | – |
| Q1 2023 | $11 | -31.2% | 1,700 | -19.0% | 0.00% | – |
| Q4 2022 | $16 | -100.0% | 2,100 | -76.9% | 0.00% | – |
| Q3 2022 | $96,000 | +5.5% | 9,100 | -19.5% | 0.00% | – |
| Q2 2022 | $91,000 | +40.0% | 11,300 | +24.2% | 0.00% | – |
| Q1 2022 | $65,000 | +66.7% | 9,100 | +295.7% | 0.00% | – |
| Q4 2021 | $39,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 500 | $3,335 | 0.00% |
| SIMPLEX TRADING, LLC | 1,700 | $11 | 0.00% |